The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection

By Lehner T.  

Trends in Immunology, Vol. 23, Iss. 7, 2002-07 ,pp. : 347-351

Elsevier

Access to resources Recommend Favorite

CXCR3 and CCR5 Ligands in Rheumatoid Arthritis Synovium

By Patel D.D.   Zachariah J.P.   Whichard L.P.  

Clinical Immunology, Vol. 98, Iss. 1, 2001-01 ,pp. : 39-45

Academic Press

Access to resources Recommend Favorite

The Oral Administration of Low-Dose Antigen Induces Activation Followed by Tolerization, While High-Dose Antigen Induces Tolerance without Activation

By Yoshida T.   Hachimura S.   Kaminogawa S.  

Clinical Immunology, Vol. 82, Iss. 3, 1997-03 ,pp. : 207-215

Academic Press

Access to resources Recommend Favorite

Immunization with mannosylated peptide induces poor T cell effector functions despite enhanced antigen presentation

By Kel Junda. M.   de Geus Eveline D.   van Stipdonk Marianne J.   Drijfhout Jan W.   Koning Frits   Nagelkerken Lex  

International Immunology, Vol. 20, Iss. 1, 2008-01 ,pp. : 117-127

Oxford University Press

Access to resources Recommend Favorite

Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis

By Hecht I.  

International Immunology, Vol. 15, Iss. 1, 2003-01 ,pp. : 29-38

Oxford University Press

Access to resources Recommend Favorite